PharmaCielo Ltd. (TSXV:PCLO)
Canada · Delayed Price · Currency is CAD 0.0600
0.00 (0.00%)
Aug 28, 2026, 12:01 PM EST
PharmaCielo Balance Sheet
Financials in millions CAD. Fiscal year is April - March.
Millions CAD. Fiscal year is Apr - Mar.
Assets
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Cash & Equivalents | 0.08 | 0.02 | 0.05 | 0.15 | 0.06 | 0.17 |
Short-Term Investments | - | - | - | - | - | 0.15 |
Cash & Short-Term Investments | 0.08 | 0.02 | 0.05 | 0.15 | 0.06 | 0.33 |
Cash Growth | 1084.80% | -67.63% | -63.42% | 137.92% | -80.93% | -94.21% |
Accounts Receivable | 0.43 | 0.31 | 0.47 | 0.34 | 0.23 | 0.61 |
Other Receivables | - | 0.58 | 0.49 | 0.25 | 0.53 | 0.79 |
Receivables | 0.43 | 0.89 | 0.96 | 0.6 | 0.76 | 1.41 |
Inventory | 1.75 | 1.96 | 1.37 | 1.5 | 2.31 | 2.13 |
Prepaid Expenses | 0.92 | 0.68 | 0.03 | 0.18 | 0.19 | 0.15 |
Total Current Assets | 3.18 | 3.56 | 2.41 | 2.44 | 3.33 | 4.02 |
Property, Plant & Equipment | 9.56 | 9.01 | 16.12 | 15.73 | 18.71 | 20.62 |
Long-Term Investments | - | - | - | 0.23 | 0.21 | 0.2 |
Long-Term Accounts Receivable | - | - | - | - | 0.04 | 0.27 |
Total Assets | 12.75 | 12.57 | 18.53 | 18.39 | 22.29 | 25.12 |
Liabilities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Accounts Payable | 5.2 | 4.27 | 5.02 | 5.24 | 5.63 | 6.11 |
Accrued Expenses | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
Current Portion of Long-Term Debt | 18.21 | 18.16 | 17.61 | 15.85 | 15.71 | 0.55 |
Current Portion of Leases | - | - | - | - | 0.04 | 0.27 |
Other Current Liabilities | - | 1.1 | 0.74 | 0.12 | - | - |
Total Current Liabilities | 23.44 | 23.55 | 23.4 | 21.23 | 21.42 | 6.95 |
Long-Term Debt | - | - | 4.62 | 4.68 | 2.55 | 11.73 |
Long-Term Leases | - | - | - | - | - | 0.04 |
Total Liabilities | 23.44 | 23.55 | 28.02 | 25.91 | 23.97 | 18.72 |
Shareholders' Equity
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Common Stock | 170.02 | 169.12 | 168.15 | 167.01 | 165.98 | 161.71 |
Retained Earnings | -215.1 | -213.66 | -210.08 | -207.85 | -198.71 | -182.41 |
Comprehensive Income & Other | 34.38 | 33.55 | 32.44 | 33.32 | 31.05 | 27.09 |
Shareholders' Equity | -10.7 | -10.98 | -9.49 | -7.52 | -1.68 | 6.39 |
Total Liabilities & Equity | 12.75 | 12.57 | 18.53 | 18.39 | 22.29 | 25.12 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Total Debt | 18.21 | 18.16 | 22.23 | 20.52 | 18.31 | 12.59 |
Net Cash (Debt) | -18.14 | -18.14 | -22.18 | -20.38 | -18.25 | -12.26 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.09 | -0.10 | -0.13 | -0.12 | -0.11 | -0.08 |
Filing Date Shares Outstanding | 207 | 211.28 | 187.98 | 175.72 | 169.14 | 155.24 |
Total Common Shares Outstanding | 207 | 200.14 | 187.98 | 175.72 | 169.14 | 154.96 |
Working Capital | -20.26 | -19.99 | -20.99 | -18.8 | -18.09 | -2.94 |
Book Value Per Share | -0.05 | -0.05 | -0.05 | -0.04 | -0.01 | 0.04 |
Tangible Book Value | -10.7 | -10.98 | -9.49 | -7.52 | -1.68 | 6.39 |
Tangible Book Value Per Share | -0.05 | -0.05 | -0.05 | -0.04 | -0.01 | 0.04 |
Land | - | 1.12 | 7.03 | 6.8 | 7.05 | 6.21 |
Buildings | - | 11.74 | 11.56 | 10.96 | 12.46 | 10.48 |
Machinery | - | 7.14 | 6.75 | 6.45 | 6.79 | 9.16 |